Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?

Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk

Counterpoint: Should Systemic Lytic Therapy Be Used for Submassive Pulmonary Embolism? No

A MET a Day Keeps Arrhythmia at Bay: The Association Between Exercise or Cardiorespiratory Fitness and Atrial Fibrillation

Can We IMPROVE Bleeding Risk Assessment for Acutely Ill, Hospitalized Medical Patients?

Trifecta or Triple Threat? The Challenge of Post-PCI Management in Patients Receiving Chronic Oral Anticoagulant Therapy

Thromboinflammation and the hypercoagulability of COVID‐19

Anticoagulant therapy for splanchnic vein thrombosis

Warfarin Sensitivity Genotyping: A Review of the Literature and Summary of Patient Experience

The HAS-BLED Score and Renal Failure: Response

NSAIDs, Risks, and Gastroprotective Strategies: Current Status and Future

Thalidomide Therapy and Deep Venous Thrombosis in Multiple Myeloma

Left Atrial Reduction Plasty: A Novel Technique

POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes

Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective